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Objectives: To estimate the prevalence of, and
explore potential risk factors for, taste and smell
dysfunction in the general population of the USA.
Design: A cross-sectional study.
Setting: A cross-sectional analysis of data collected in
the National Health and Nutrition Examination Survey
(NHANES 2013–2014).
Participants: A total of 3519 men and women
aged 40 years and older who participated in NHANES
2013–2014.
Main outcome measures: Using the NHANES
Pocket Smell Test, smell impairment was defined as
failing to correctly identify 6 or more of the 8 odours.
Taste impairment was defined as failing to correctly
identify quinine or sodium chloride.
Results: The estimated prevalence was 13.5% for
smell impairment, 17.3% for taste impairment and
2.2% for taste and smell impairment. For smell, but
not taste, prevalence estimates increased with age and
were higher in men and ethnic minorities. In backward
stepwise logistic regression, low educational
attainment, low family income and a history of asthma
or cancer were independently associated with a higher
prevalence of smell impairment, whereas light-to-
moderate alcohol consumption (1–3 drinks/day) was
associated with a lower prevalence of this condition.
After multivariate adjustment, being non-Hispanic Black
Americans, consuming ≥4 drinks of alcohol per day
and having a history of cardiovascular disease (CVD)
were independently associated with a higher prevalence
of taste impairment.
Conclusions: Based on a nationally representative
multistage probability survey among the US
population aged 40 years and older, smell and taste
dysfunction affected ∼20.5 million (13.5%) and 26.3
million (17.3%) individuals, respectively. Age,
gender, ethnicity, educational attainment, family
income, light-to-moderate alcohol consumption and
history of asthma or cancer were significant risk
factors for smell dysfunction, whereas only ethnicity,
heavy alcohol consumption and CVD history were
associated with a higher prevalence of taste
dysfunction.
INTRODUCTION
Smell and taste disorders pose a major threat
to public health, signiﬁcantly compromising
quality of life, food preferences, nutritional
status and safety from airborne toxins, ﬁre,
smoke, spoiled food and leaking natural
gas.1–4 It is now well established that a dispro-
portionate number of the elderly experience
smell dysfunction that has direct conse-
quences for health and safety.3 5 6 For
example, in one longitudinal study of 1162
non-demented older persons, the mortality
rate over a 4-year period was 45% for those
with lowest baseline olfactory test scores,
when compared with a rate of 18% in those
with the highest test scores, even after
controlling for age and other confounders.7
Although a large literature suggests that
chemosensory disorders are relatively
common,2 8–16 there remains a lack of
consensus as to the prevalence of such disor-
ders in population-based epidemiological
studies.8 12 17–22 Previous studies attempting
to address this issue have provided preva-
lence estimates ranging from 2.7% to 24.5%
for smell dysfunction,8–11 13 17 19 20 and 0.6%
Strengths and limitations of this study
▪ The present study provides a nation-
representative estimates of the prevalence of
taste and smell impairment among men and
women aged 40 years and above in the US
population.
▪ This study demonstrates associations of age,
gender, ethnicity, educational attainment, family
income, alcohol consumption and history of
asthma, cancer or cardiovascular disease with
chemosensory disorders on a nationwide scale.
▪ This is a cross-sectional study, which limits its
ability to infer causal relationships between risk
factors and taste and smell impairments.
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to 20% for taste dysfunction.10 17 20 22 Such variation
likely reﬂects differences in test methods, criteria for
deﬁning dysfunction and both sample sizes and sam-
pling procedures, as well as variations in sex, age, health
and ethnic composition of the sampled populations.
The relatively recent addition of olfactory and
gustatory testing to the National Health and Nutrition
Examination Survey (NHANES), a survey that focuses on
representative samples of non-institutionalised persons
from 15 counties or other geographic jurisdictions ran-
domly selected within the USA each year, provides a
unique opportunity to obtain sound nationwide estimates
of prevalence of chemosensory dysfunction. An evalu-
ation of the olfactory data collected during a single-year
survey (2012) reported a 12.4% prevalence for smell dys-
function in the sampled population, although estimates
of taste dysfunction were not presented.21 In the present
study, based on a larger sample size from the NHANES
2013–2014 survey among US population aged 40 years
and older, we aimed to estimate the prevalence of olfac-
tory and taste dysfunction in the US population, and
explore potential risk factors for these conditions.
METHODS
Study participants
NHANES is a cross-sectional survey designed to assess
the health and nutritional status of adults and children
in the USA. Each year, the survey examines a nationally
representative sample of about 5000 people who are
located in 15 counties randomly selected across the
country. The taste and smell examination was a new
health examination component which was performed
among participants aged 40 years and older.18 A total of
3708 men and women were enrolled in the taste and
smell examination. A short screening questionnaire and
a test of perceived taste intensity were then used to
assess eligibility for the study.23 Participants were
excluded from smell and taste examinations if they were:
(1) pregnant or lactating; (2) allergic to quinine (per-
tinent to the quinine taste test only) or (3) unable to
correctly rate the brightness of a standard series of three
lights in an LED luminescence panel (pertinent to
understanding the procedures of the taste test only).
These exclusions left 3114 participants who completed
the quinine and sodium chloride (NaCl) taste tests and
3519 participants who completed the 8-item smell test.
The mean (SEM) age of NHANES participants
(n=3114) included in the taste test was 57.5 (0.3) years;
48.6% were men. Regarding ethnic distribution, 72.8%
were non-Hispanic Whites, 10.1% non-Hispanic Blacks
and 6.6% Mexican Americans. For the smell test, the
mean (SE) age of NHANES participants (n=3519) was
57.8 (0.3) years; 47.7% were men. Of these participants,
71.2% were non-Hispanic Whites, 10.6% non-Hispanic
Blacks, 6.9% Mexican Americans and 11.3% other
races/ethnicities (including other Hispanic and multi-
racial individuals).
The NHANES protocol was approved by the National
Center for Health Statistics (NCHS) institutional review
board, and written informed consent was obtained from
all participants.
Smell and taste tests
For smell testing, the two four-item versions (A and B)
of the NHANES Pocket Smell Test (Sensonics
International, Haddon Heights, New Jersey, USA), devel-
oped in conjunction with the NIH, were sequentially
administered, resulting an eight-item ‘scratch and sniff’
test.23 The eight odorants (chocolate, strawberry, smoke,
leather, soap, grape, onion and natural gas) were pre-
sented in a ﬁxed order. A participant was required, in a
forced-choice situation, to identify each odorant from
four alternative names. Smell impairment was deﬁned as
not being able to correctly identify six or more of
the eight odours, each from a list of four possible
responses.8 A recent validation study demonstrated
moderate-to-good test–retest reliability of the NHANES
smell protocol (intraclass correlations were 0.82 and
0.69 for 2-week and 6-month intervals, respectively).23
Of note, the eight odorants used in NHANES test are
components of the 40-item University of Pennsylvania
Smell Identiﬁcation Test (UPSIT).24 Our deﬁnition of
smell impairment approximately corresponds to the def-
inition of being unable to correctly identify 29 or more
of the 40 odours using the UPSIT test (see online
supplementary table S1).
The taste tests employed in this NHANES survey
included a tongue tip taste test and a whole-mouth taste
test. In the tongue tip test, the taste stimuli (0.32 mg/
mL quinine (bitter) and 58.5 mg/mL NaCl (salty) in
10 mL solution) were presented on a cotton swab that
was gently moved across the tip of the tongue in a stan-
dardised manner.23 Participants were asked to identify
the taste (salty, bitter, sour, something else, no taste) and
rate the perceived intensity on the Generalised Labelled
Magnitude Scale.25 A 30 s interval was interspersed
between stimulus presentations, during which time parti-
cipants rinsed their mouths with water. In the whole-
mouth taste test, participants swished 10 mL of each
tastant solution (19.5 mg/mL NaCl, 58.5 mg/mL NaCl
or 0.32 mg/mL quinine) for 3 s, expectorated and
rinsed their mouths with water. The participants then
were asked to identify the taste quality and rate the solu-
tion’s intensity on a standardised scale. As a replication
test, another whole-mouth taste test for salt was per-
formed at the end of the chemosensory test. The partici-
pants were randomised to receive either a 0.32 M NaCl
or a 1 M NaCl salt solution.
A recent test–retest reliability and validity examination
of NHANES taste test protocol demonstrated a reason-
able correlation between quinine whole-mouth measure-
ment (0.32 mg/mL) and other taste measurements,
including tongue tip tests of NaCl (r=0.53) and quinine
(r=0.44), and whole-mouth tests of NaCl (r=0.60 for
19.5 mg/mL NaCl and 0.77 for 58.5 mg/mL NaCl),
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sucrose, citric acid and propylthiouracil, suggesting that
the whole-mouth quinine assessment was a reasonable
assessment for overall taste functioning.23 Thus, in our
study, instead of intensity ratings, failing to correctly
identify quinine in the whole-mouth test was used to
deﬁne taste dysfunction. In sensitivity analyses, we
deﬁned taste impairment as failing to correctly identify
quinine (tongue tip and whole-mouth test) or NaCl
(tongue tip and whole-mouth test).
Demographics and related information
The NHANES survey employed a computer-assisted
personal interview system. The inhome questionnaire
obtained information on age, sex, race/ethnicity
(non-Hispanic White, non-Hispanic Black, Mexican
American and other race),26 educational attainment
(high school or below, some college, college, graduate
school or above), ratio of family income to poverty (PIR;
categorised as low (PIR<1.3), middle (1.3≤PIR≤3.5) and
high (PIR>3.5)),26 smoking status (never smoker, past
smoker, current smoker: <10, 10–20, >20 cigarettes/day),
alcohol consumption (non-drinker, 1–3 or ≥4 drinks/
day), self-reported chronic diseases (diabetes, cardiovas-
cular disease (CVD), asthma and cancer), pesticide use
in home (yes, no), self-reported taste and smell pro-
blems (deﬁned as reporting problems within the past
year) and conditions that might inﬂuence taste and
smell ability (frequent nasal congestion, head injury,
tonsillectomy, broken nose/serious injury to face or
skull and sinus infection). Symptoms of depression
were assessed using the nine-item Patient Health
Questionnaire scale (PHQ-9, possible range 0–27). A
cut-off point ≥10 was used to identify participants with
moderate-to-severe depression.27 To estimate physical
activity, metabolic equivalent values (MET-min/week)
were calculated by using the sum of the MET score
multiplied by the average time per week of speciﬁc phys-
ical activity and subsequently categorising the scores into
tertile levels of physical activity.28 Blood pressure (BP)
and anthropometric measurements were performed by
trained health technicians in the mobile examination
centres. BP was measured three times, and the mean
values of the last two measurements were used in the
analysis. Hypertension was deﬁned as systolic BP ≥140 or
diastolic BP ≥90 mmHg, or positive answers to the ques-
tions, ‘Now taking prescribed medicine for high BP’ or
‘Told had high BP 2+ times’. Body mass index (BMI) was
calculated as weight in kilograms divided by height in
metres squared. Obesity was deﬁned as BMI ≥30 kg/m2.
Statistical analysis
Owing to the NHANES sampling design, the sample
weights were incorporated into the analysis whenever
possible. We used the number 15 (the number of
primary sampling units minus the number of sampling
strata) for the df. A SAS procedure—PROC
SURVEYFREQ—was used to estimate the weighted
prevalence of taste and smell disorders in the total
population as well as within subgroups of the popula-
tion. The comparison between participants with and
without taste or smell disorder was tested using the Wald
F-test in the PROC SURVEYREG for continuous
variables or the Rao-Scott χ2 test in the PROC
SURVEYFREQ for categorical variables. Logistic regres-
sion (PROC SURVEYLOGISTIC) was used to estimate
the age-adjusted and sex-adjusted ORs and 95% CIs of
taste and smell disorders for common socioeconomic,
demographic and lifestyle characteristics that may serve
as risk factors of the disorders, including BMI, race/
ethnicity, educational attainment, family income,
smoking status, alcohol use, physical activity, depression,
hypertension, obesity, diabetes, CVD, asthma, cancer,
pesticide use, frequent nasal congestion, head injury,
tonsillectomy, broken nose or serious injury to face or
skull and sinus infection. To minimise sample reduction
due to missing covariates, indicator variables were used
for missing categorical variables. We used a SAS macro
(%StepSvylog) to perform backward model selection for
the survey data. Potential risk factors with p<0.25 were
entered together into a multivariable logistic model and
then successively removed until all retained variables
had a p<0.05.29 Finally, to assess the capacity of selected
risk factors in predicting smell and taste disorder, we
plotted a receiver operating characteristic (ROC) curve
and calculated a sample-weighted area under the ROC
curve (AUC) that incorporated the NHANES sampling
design.
Data were analysed with the SAS software package,
V.9.4 (SAS Institute, Cary, North Carolina, USA), and
STATA, V.12.0 (Stata Corporation, College Station, Texas,
USA). Two-sided p<0.05 was considered statistically
signiﬁcant.
RESULTS
The overall estimated prevalence of smell impairment
was 13.5%, whereas it was 17.3% for taste impairment.
The estimated prevalence of having a taste and smell dis-
order was 2.2%. Thus, about 28.6% of the US adult
population aged 40 years and older appears to have
either a smell or taste problem or both.
Figure 1 shows the prevalence estimates of smell and
taste disorders according to age, sex and ethnicity. For
smell dysfunction, the estimates signiﬁcantly increased
with age in men and women. In addition, compared
with women, men had a higher prevalence in each age
group, especially in the group of 70 years and older
(men: 37.2%; women: 25.2%). Regarding race/ethnic
distribution, compared with non-Hispanic White
Americans, ethnic minorities, namely non-Hispanic
Black Americans, Mexican Americans and other races/
ethnicities, had a higher estimated prevalence of smell
impairment. In contrast, no such patterns of relationship
were found between these demographic variables and
the prevalence of taste dysfunction. Paradoxically, the
estimated prevalence of taste dysfunction decreased with
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age in women, but not in men. Online supplementary
ﬁgure S1 shows mean (SE) NHANES Pocket Smell Test
scores according to age and gender. Regarding taste
impairment, non-Hispanic Black Americans had a
higher prevalence of than that in other ethnic groups
(22.9% for non-Hispanic Black, 17.1% for non-Hispanic
White, 15.6% for Mexican American and 13.9% for
other race). Online supplementary ﬁgure S2 demon-
strates the prevalence of taste and smell impairment by
age, sex and ethnicity. Regarding individual smell test
items of all the participants, 4.3% incorrectly identiﬁed
the odour of onion, 6.7% of soap, 9.5% of smoke,
12.3% of natural gas, 16.1% of chocolate, 18.7% of
strawberry, 20.6% of leather and 30.4% of grape. In the
age group of 70 years and older, the corresponding pro-
portions reached 21.2% for smoke and 26.3% for
natural gas (see online supplementary ﬁgure S3).
The characteristics of the study population by smell
and taste disorder status are shown in table 1. In univari-
ate comparisons, in addition to the demographic
characteristics, participants with smell impairment
tended to have lower levels of educational attainment,
physical activity, family income and alcohol consumption
than other participants. Moreover, they had a higher
prevalence of hypertension, diabetes, CVD, cancer and
self-reported taste and smell problems (p<0.05). Other
factors, including BMI, smoking, obesity, depression, the
history of asthma, pesticide use, nasal congestion, tonsil-
lectomy and head injury, were not associated with smell
dysfunction. Age and ethnicity were associated with the
prevalence of taste impairment.
After adjusting for age, gender and ethnicity, the
prevalence of smell and taste disorders was differentially
associated with other socioeconomic, lifestyle and
medical history variables (table 2). Educational attain-
ment, family income, physical activity, alcohol consump-
tion and a history of hypertension, CVD or cancer were
signiﬁcantly associated with the prevalence of olfactory
dysfunction. Educational attainment and a history of
asthma were signiﬁcantly associated with the prevalence
of taste dysfunction.
In backward stepwise selection, older age, male gender,
ethnic minorities (including non-Hispanic Black and
Mexican American), low family income, low educational
attainment and a history of asthma or cancer remained in
the model and were independently associated with an
increased prevalence of smell impairment (OR and 95%
CI was 1.37 (1.30 to 1.45) for age, 1.68 (1.27 to 2.22) for
men, 1.91 (1.36 to 2.67) for non-Hispanic Black, 1.45
(1.04 to 2.01) for low family income, 1.33 (1.17 to 1.52)
for low education attainment, 1.38 (1.05 to 1.83) for
cancer and 1.39 (1.02 to 1.89) for asthma; all p<0.05). In
contrast, light-to-moderate alcohol consumption (1–3
drinks/day) was signiﬁcantly associated with a decreased
Figure 1 Prevalence of smell and taste impairment according to age, sex and race/ethnicity. (A and B) The prevalence of smell
and taste impairment in men and women according to each age group. (C and D) The prevalence of smell and taste impairment
in different ethnicities according to each age group.
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prevalence of smell impairment (OR and 95% CI 0.72
(0.58 to 0.91), p<0.01) (table 3). For taste dysfunction,
non-Hispanic Black (OR and 95% CI 1.46 (1.07 to 1.99),
p=0.02), high alcohol consumption (≥4 drinks/days) (OR
and 95% CI 1.42 (1.04 to 1.94), p=0.03) and a history of
CVD (OR and 95% CI 1.30 (1.02 to 1.67), p=0.04) were
signiﬁcantly associated with a higher prevalence of
impairment, whereas age was inversely associated with the
prevalence of this condition (each 5-year increment; OR
and 95% CI 0.93 (0.89 to 0.97), p=0.01) (table 3).
Age (each 5-year increment; OR and 95% CI 1.22
(1.08 to 1.38), p<0.01), physical inactivity (OR and 95%
CI 2.38 (1.21 to 4.70), p<0.05) and head injury (OR and
95% CI 2.15 (1.10 to 4.18), p<0.05) were signiﬁcantly
Table 1 Characteristics of study participants according to smell and taste impairment status*
Smell impairment Taste impairment
Characteristic Yes (n=630) No (n=2889) p Value Yes (n=540) No (n=2574) p Value
Age, years (mean±SE) 65.0±0.6 56.7±0.2 <0.001 55.9±0.6 57.8±0.3 0.01
BMI, kg/m2 (mean±SE) 29.5±0.4 29.5±0.2 0.91 29.6±0.5 29.6±0.2 0.99
Men, % 56.2 (3.1) 46.4 (1.0) 0.005 49.2 (1.6) 48.5 (1.0) 0.72
Race/ethnicity, % 0.005 0.04
Non-Hispanic White 64.3 (3.6) 72.3 (3.2) 72.1 (3.9) 72.9 (3.1)
Non-Hispanic Black 14.1 (2.1) 10.0 (1.4) 13.5 (2.1) 9.5 (1.4)
Mexican American 7.7 (2.4) 6.8 (1.6) 5.9 (2.0) 6.7 (1.5)
Other 13.9 (1.2) 10.9 (1.1) 8.5 (1.4) 10.9 (1.2)
Educational attainment <0.001 0.29
<High school 49.5 (2.7) 35.4 (2.4) 38.8 (3.0) 35.1 (2.9)
Some college 25.7 (2.3) 31.3 (1.4) 31.7 (2.2) 31.0 (1.9)
College graduate or above 24.8 (2.3) 33.3 (2.3) 29.5 (3.6) 33.9 (2.3)
Physical activity, METs/week <0.001 0.33
Tertile 1 40.9 (2.0) 29.5 (1.4) 29.7 (1.9) 29.2 (1.3)
Tertile 2 32.1 (2.4) 32.0 (1.0) 36.7 (4.1) 31.7 (1.1)
Tertile 3 27.0 (2.2) 38.5 (1.5) 33.6 (3.9) 39.1 (1.9)
Ratio of family income to poverty, % <0.001 0.20
<1.3 25.2 (2.4) 19.1 (2.7) 20.1 (2.7) 18.0 (2.8)
1.3–3.5 43.8 (1.8) 32.8 (1.2) 37.8 (2.5) 33.7 (1.2)
>3.5 31.0 (3.0) 48.0 (3.0) 42.1 (3.0) 48.2 (3.4)
Smoking status, % 0.25 0.28
Never 51.8 (2.8) 53.7 (2.0) 50.1 (3.4) 53.6 (2.0)
Past 33.8 (2.9) 28.2 (1.3) 28.6 (3.4) 29.4 (1.3)
Current <10 cigarettes/day 8.1 (1.0) 9.7 (0.6) 10.3 (1.6) 9.1 (0.6)
Current 10–20 cigarettes/day 2.0 (0.9) 2.0 (0.2) 3.0 (1.1) 1.9 (0.3)
Current >20 cigarettes/day 4.3 (1.6) 6.4 (1.0) 8.0 (1.5) 6.0 (1.1)
Alcohol consumption (drinks/day) <0.001 0.07
Non-drinkers 49.4 (2.6) 31.4 (2.1) 31.2 (3.5) 32.2 (2.2)
1–3 drinks/day 44.1 (2.3) 59.1 (2.3) 55.9 (3.5) 58.9 (2.4)
≥4 drinks/day 6.5 (1.7) 9.5 (0.8) 12.9 (1.5) 8.9 (0.8)
Depression symptom, % 10.0 (2.0) 9.1 (0.9) 0.59 7.7 (1.0) 9.0 (1.0) 0.31
Hypertension, % 63.9 (2.4) 46.4 (1.1) <0.001 49.6 (2.3) 47.5 (1.5) 0.51
Obesity, % 37.9 (2.2) 40.3 (1.5) 0.36 42.7 (2.9) 39.7 (1.6) 0.31
Diabetes, % 21.2 (1.5) 14.8 (1.0) <0.001 15.7 (2.3) 15.0 (1.0) 0.75
CVD, % 24.4 (2.0) 11.2 (0.7) <0.001 12.7 (1.6) 12.3 (0.8) 0.79
Asthma, % 16.5 (2.0) 13.9 (0.8) 0.20 16.0 (2.1) 13.8 (0.7) 0.26
Cancer, % 23.9 (2.1) 14.8 (0.6) <0.001 12.7 (1.9) 16.6 (1.0) 0.16
Pesticide use, % 18.1 (1.6) 18.4 (1.0) 0.90 16.3 (1.9) 18.6 (0.9) 0.26
Self-report taste problem, % 10.7 (1.6) 4.1 (0.4) <0.001 3.8 (1.1) 4.7 (0.6) 0.55
Self-report smell problem, % 19.5 (2.2) 6.1 (0.9) <0.001 8.9 (1.3) 7.8 (0.9) 0.36
Frequent nasal congestion, % 28.3 (2.0) 31.4 (0.9) 0.21 29.8 (2.8) 31.2 (1.0) 0.67
Head injury, % 15.0 (1.5) 16.7 (1.0) 0.25 17.4 (2.1) 16.9 (1.2) 0.84
Tonsillectomy, % 34.9 (3.2) 32.3 (1.3) 0.41 32.0 (2.8) 32.7 (1.3) 0.80
Broken nose or serious injury to face/skull, % 18.1 (1.6) 17.5 (1.4) 0.78 18.9 (2.4) 17.7 (1.4) 0.51
There were 28 participants with missing values for BMI; 112–279 participants with missing values for hypertension, family income, pesticide
use and depression symptom; 2–7 participants with missing values for self-reported taste problem, self-reported smell problem, frequent nasal
congestion, head injury and broken nose or serious injury to face/skull.
*Data are mean±SE, or % (SE).
BMI, body mass index; CVD, cardiovascular disease.
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Table 2 Demographic-adjusted ORs of smell and taste impairment by socioeconomic characteristics, lifestyle factors and
medical history*
Smell impairment Taste impairment
Variable OR (95% CI) p Value OR (95% CI) p Value
Education level
Low vs high 1.69 (1.30 to 2.20) <0.001 1.29 (1.00 to 1.67) 0.05
Ratio of family income to poverty
<1.3 vs >3.5 1.80 (1.35 to 2.40) <0.001 1.28 (0.84 to 1.94) 0.25
Smoking status
Past vs never 0.99 (0.78 to 1.27) 0.96 1.11 (0.80 to 1.56) 0.53
<10 cigarettes/day vs never 1.06 (0.75 to 1.50) 0.76 1.12 (0.77 to 1.65) 0.55
10–20 cigarettes/day vs never 1.36 (0.50 to 3.68) 0.55 1.66 (0.70 to 3.93) 0.25
>20 cigarettes/day vs never 1.00 (0.44 to 2.28) 0.99 1.39 (0.99 to 1.95) 0.06
Alcohol use
1–3 drinks/day vs non-drinkers 0.58 (0.47 to 0.71) <0.001 0.83 (0.63 to 1.10) 0.20
≥4 drinks/day vs non-drinkers 0.66 (0.33 to 1.30) 0.23 1.22 (0.90 to 1.65) 0.21
Physical activity
Tertile 1 vs tertile 3 1.61 (1.27 to 2.05) <0.001 1.28 (0.90 to 1.83) 0.17
Depression 1.17 (0.77 to 1.79) 0.46 0.85 (0.62 to 1.18) 0.34
Hypertension 1.31 (1.03 to 1.67) 0.03 1.23 (0.95 to 1.59) 0.13
Obesity 1.02 (0.80 to 1.30) 0.87 1.10 (0.84 to 1.44) 0.48
Diabetes 1.15 (0.91 to 1.44) 0.24 1.15 (0.81 to 1.62) 0.44
CVD 1.53 (1.16 to 2.02) 0.003 1.19 (0.93 to 1.52) 0.15
Asthma 1.36 (0.96 to 1.91) 0.08 1.45 (1.05 to 2.00) 0.03
Cancer 1.35 (1.02 to 1.80) 0.04 0.80 (0.47 to 1.37) 0.43
Pesticide use 0.87 (0.64 to 1.17) 0.34 0.86 (0.65 to 1.14) 0.30
Frequent nasal congestion 0.90 (0.71 to 1.15) 0.40 0.95 (0.70 to 1.27) 0.70
Head injury 0.99 (0.75 to 1.31) 0.93 1.03 (0.72 to 1.46) 0.88
Tonsillectomy 0.93 (0.66 to 1.32) 0.69 1.05 (0.78 to 1.43) 0.74
Broken nose or serious injury to face/skull 1.19 (0.89 to 1.59) 0.25 1.08 (0.84 to 1.39) 0.56
*Adjusted for age, sex and race/ethnicity.
CVD, cardiovascular disease.
Table 3 Backward stepwise logistic regression model for smell and taste disorders
Smell impairment Taste impairment
Variable OR (95% CI) p Value OR (95% CI) p Value
Age (per 5-year increment) 1.37 (1.30 to 1.45) <0.001 0.93 (0.89 to 0.97) 0.01
Sex <0.001
Women 1 (reference)
Men 1.68 (1.27 to 2.22) –
Race/ethnicity <0.001
Non-Hispanic White 1 (reference) 1 (reference)
Mexican American 1.68 (1.02 to 2.76) –
Non-Hispanic Black 1.91 (1.36 to 2.67) 1.46 (1.07 to 1.99) 0.02
Ratio of family income to poverty 0.03
<1.3 vs >3.5 1.45 (1.04 to 2.01) –
Education level <0.001
Low vs high 1.33 (1.17 to 1.51) –
Alcohol use <0.01
1–3 drinks/day vs non-drinker 0.72 (0.58 to 0.91) –
≥4 drinks/day vs non-drinker – 1.42 (1.05 to 1.93) 0.03
CVD – 1.30 (1.02 to 1.67) 0.04
Cancer 1.38 (1.05 to 1.83) 0.02 –
Asthma 1.39 (1.02 to 1.89) 0.03 –
–, not included in the final model.
CVD, cardiovascular disease.
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associated with a higher prevalence of having taste and
smell dysfunction.
Figure 2 shows that age, sex and ethnicity render an
AUC of 0.72 for smell dysfunction. Further inclusion of
socioeconomic, lifestyle and medical risk factors only
marginally increased the AUC to 0.74. For taste impair-
ment, an AUC of 0.57 was estimated for a model that
included age, ethnicity, heavy alcohol consumption and
a history of CVD.
In a secondary analysis, similar results regarding the
risk factors for taste and smell impairment were
observed when analyses were restricted to the partici-
pants aged 40–60 years, although some of the associa-
tions did not reach statistical signiﬁcance probably due
to reduced power (data not shown). In the sensitivity
analyses, when we deﬁned taste disorder as being unable
to correctly identify either quinine or NaCl, we esti-
mated a prevalence of 14.0%. In addition, with this alter-
native deﬁnition, the associations of Black ethnicity,
heavy alcohol consumption and a CVD history with the
prevalence of taste disorder were attenuated to non-
signiﬁcance (OR and 95% CI 1.25 (0.98 to 1.59) for
Black ethnicity; 1.20 (0.86 to 1.67) for heavy alcohol
consumption and 1.15 (0.85 to 1.55) for CVD).
DISCUSSION
In this most current nationwide representative sample of
US men and women aged 40 years and older, a signiﬁ-
cant number of US adults were found to experience
smell or taste problems. The overall estimated preva-
lence of smell and taste impairment was 13.5% and
17.3%, respectively. Signiﬁcant differences were
observed in the estimated prevalence of smell impair-
ment among subgroups deﬁned by age, gender and eth-
nicity. Such differences were not evident for the
estimated prevalence of taste dysfunction. In our multi-
variate analysis, a multitude of potential risk factors,
including age, sex, race/ethnicity, family income, educa-
tional attainment, alcohol consumption and a history of
asthma or cancer, were independently associated with
the prevalence of smell impairment. Non-Hispanic Black
ethnicity, high alcohol consumption and a history of CVD
were signiﬁcantly associated with a higher prevalence of
taste impairment after adjustment for confounders.
Our nationally representative estimate of the overall
prevalence of smell dysfunction (13.5%) was quite
similar to the estimate based on a single-year NHANES
survey (12.4%).21 These estimates were somewhat lower
than that reported in other populations whose preva-
lence ranged from 18.0% to 24.5%,8 9 11 17 and some-
what higher than that reported by some other studies
(2.7% to 3.8%).10 19 Differences between the test proce-
dures (eg, odorants, psychophysical paradigms) and the
study populations (eg, age, sex and health status) are
presumably involved (see online supplementary table
S2). Using the 40-item UPSIT, Doty et al13 found little
age-related decline in smell function until the sixth
decade of life, at which time a precipitous age-related
decline occurred, illustrating how age would be
expected to markedly inﬂuence prevalence. Of particu-
lar importance in establishing prevalence are the criteria
used to deﬁne dysfunction, which vary considerably
among studies. In two studies, being unable to identify
75% of either 4 or 12 odorants was deﬁned as dysfunc-
tion.9 12 Other studies have set this criterion at 62.5%
for either 8 or 16 odorants,6 14 21 and 40% for 5 odor-
ants.9 Such variations in criteria signiﬁcantly inﬂuence
the estimated prevalence and likely explain much of the
variation seen among prevalence studies. Our study, like
most others, has the limitation of employing a relatively
few number of odorants. Despite this limitation,
however, our criterion for deﬁning smell impairment
(ie, <75% or 6/8 items) corresponds to dysfunction
deﬁned by the 40-item UPSIT. Correctly identifying six
out of eight items corresponds to an UPSIT score of 30,
which is the cut-point between mild and moderate
microsmia.24
Only a limited number of epidemiological studies
have estimated the prevalence of taste dysfunc-
tion.10 17 20 22 In the 1994 Disability Supplement to the
National Health Interview Survey (NHIS-D), based on
information from a self-reported taste impairment ques-
tionnaire, Hoffman et al22 found that only 0.6% of US
adults (>18 years) reported having a gustatory problem.
In the current study, using standardised taste testing, the
prevalence of taste impairment was 17.3%, whereas the
prevalence of self-reported taste impairment (deﬁned as
reporting taste problems within the past year) was only
5.3%, suggesting that self-reported estimates signiﬁcantly
underestimated the true prevalence.8 9 30 Nevertheless,
Figure 2 Receiver operating characteristic (ROC) curves
showing the capacity of selected risk factors in predicting
smell impairment in US men and women, National Health and
Nutrition Examination Survey, 2013–2014. The blue curve is
for the model adjusted for age, gender and ethnicity. The red
curve is for the model further adjusted for family income,
educational attainment, alcohol consumption and a history of
asthma or cancer. The area under the ROC was 0.72 for the
blue curve and 0.74 for the red curve.
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the prevalence of taste impairment in our study was
comparable to two other large taste testing studies that
reported prevalences of 14.8% and 20.0%.10 17
Epidemiological studies that have examined potential
risk factors for smell and taste disorders are limited.
Several have consistently found the prevalence of smell
impairment to increase with age and to be higher in
men than in women.8 11 17 21 In addition, the current
analysis demonstrated that certain ethnic groups, such
as non-Hispanic Blacks and Mexican Americans, had a
higher prevalence of smell impairment than that
observed for White Americans. In the National Social
Life, Health, and Aging Project study, Pinto et al31 also
demonstrated that older African-Americans and
Hispanics had worse olfactory function. Williams et al32
observed signiﬁcant differences between Hispanics,
African-Americans and non-Hispanic Whites in taste per-
ception. While a subtle difference was noted by Doty
et al24 between White and Black Americans in a large,
albeit convenience, sample, another study observed
equivalent UPSIT scores in White and Black American
populations and relatively higher scores in Korean
American populations.33 The discrepant results may
reﬂect differences in population characteristics, testing
methods and deﬁnitions for smell impairment.
In the current study, other socioeconomic risk factors
for smell impairment that are independent of ethnicities
were also identiﬁed, including low educational
attainment and low family income. Our ﬁndings of the
inﬂuences of these socioeconomic factors were
consistent with previous studies.4 19–21 34 Existing evi-
dence has suggested that access to healthcare, occupa-
tion and overall quality of life potentially explain the
link between low socioeconomic status and a higher
prevalence of smell disorder.35 Regarding olfactory func-
tion, besides the above ﬁndings which were mostly con-
sistent with the data from 2012 NHANES survey,21 our
results additionally demonstrated a link between a
history of asthma and cancer and a slightly higher preva-
lence of smell dysfunction. For medical history, Alobid
et al36 reported that a history of persistent asthma had a
signiﬁcant impact on smell loss in patients with nasal
polyposis. Moreover, asthma was a predictor of poor
olfactory function in patients with chronic rhinosinusi-
tis.37 Some clinical studies have also demonstrated that
smell function is signiﬁcantly decreased in patients
receiving cancer chemotherapy,38 39 and at least one
study suggest that the prevalence of self-reported taste
and smell alterations could reach as high as 86%.40 Of
note, smoking was not associated with the prevalence of
smell impairment in our cross-sectional analysis.
Accumulating evidence has suggested that smoking may
exert an adverse effect on smell function,8 17 41 although
some studies did not observe such a link.11 20 42 In
another cross-sectional population-based study, Mullol
et al9 reported that smoking and exposure to noxious
substances were even mild protective factors for smell
recognition. These mixed ﬁndings may reﬂect the cross-
sectional nature of these studies, as well as the lack of
detailed assessments of smoking dose and duration,
which are often more informative than dichotomous
smoking status. More prospective studies are warranted
to elucidate the potential adverse effect of smoking on
olfactory function.
In comparison to the data for smell impairment, fewer
associations between taste impairment and demo-
graphic/health measures were observed. We did ﬁnd
that race/ethnicity, heavy alcohol use and a history of
CVD were associated with a higher prevalence of taste
impairment. Compared with non-Hispanic White partici-
pants, non-Hispanic Black participants had a higher
prevalence of taste and smell disorders. The underlying
reason for this observation was unknown, although
other socioeconomic factors and genetic susceptibility
might partially account for this link. Interestingly, we
also found heavy drinking to be associated with an
increased prevalence of taste dysfunction, whereas
light-to-moderate drinking was associated with a
decreased prevalence of smell dysfunction, suggesting
that the amount of alcohol intake may exert distinct
effects on chemosensory perception.21 43 44 In addition,
we found a positive association between CVD and the
prevalence of altered taste. Evidence has suggested that
variations in oral sensation, inﬂuenced by genetic and
environmental factors, might increase the risk of CVD
by impacting dietary behaviours such as higher intake of
high-fat and sweet foods.45 46 However, in this cross-
sectional study, we could not exclude the possibility that
the taste function might be inﬂuenced by the medica-
tions taken by people with CVD. Unexpectedly, an
inverse association between age and the prevalence of
taste dysfunction was observed in our study, which is in
contrast to frequent reports of age-dependent reduc-
tions in taste ability.47 48 Ageing may primarily inﬂuence
the taste sensitivity to low levels of stimuli,47 but less so
for suprathreshold deﬁcits in taste. In most epidemio-
logical studies, relatively high concentrations of tastants
(24 mg/mL quinine hydrochloride; 75–100 mg/mL
NaCl; 100–200 mg/mL sucrose; 50–165 mg/mL citric
acid) have been employed,10 17 which may not be sensi-
tive enough to detect age-related taste dysfunction.49 Of
note, threshold concentrations are typically set at much
lower concentrations (eg, 3×10−4 mg/mL for quinine,
0.585 mg/mL for NaCl, 6.84 mg/mL for sucrose and
3.84 mg/mL for citric acid).49 In the NHANES, the
tastant concentrations (0.32 mg/mL for quinine, 19.5
and 58.5 mg/mL for NaCl) were much higher than the
threshold concentrations, albeit comparable to those
used in some previous epidemiological studies.10 17 This
may explain the similarity between our NHANES ﬁnd-
ings and those reported in a German population with
taste test at suprathreshold concentrations, in which a
decline trend of the prevalence of taste dysfunction was
observed in women aged 45–74 years.17
The present study provides a nation-representative esti-
mate of the prevalence of taste and smell impairment
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among men and women aged 40 years and older in the
US population. Most previous studies were only con-
ducted among older adults.8 10 12 14 15 Moreover, it has
demonstrated that chemosensory disturbances are inﬂu-
enced by a range of demographic and health factors.
Importantly, our analysis strongly suggests that a consid-
erable number of Americans suffer from chemosensory
disturbances. That being said, this research has its limita-
tions. First, it is a cross-sectional study, which limits its
ability to infer causal relationships between risk factors
and taste and smell impairments. Second, we utilised
only bitter and salt-tasting stimuli, excluding sweet and
sour-tasting ones. Furthermore, the unexpected inverse
association of taste dysfunction with age suggests that
the test used by NHANES is not sensitive enough to
capture age-related declines in taste function.
Nonetheless, there is evidence that the whole-mouth
quinine test used in our study may be a good proxy for
overall taste function, even though there are presently
no universally accepted standards to best deﬁne taste
impairment.23 Third, we measured taste and smell func-
tion on only a single occasion, which may not be repre-
sentative of longerterm function. Nevertheless, the taste
and smell measurements employed in this study have
been found to be largely reproducible over a 6-month
period.23 In addition, although a recent study demon-
strated that the NHANES taste and smell protocol has
moderate-to-good test–retest reliability,23 the face validity
of the protocol was not proven. Furthermore, the impact
of cognitive function on the validity of assessments of
smell and taste functions cannot be evaluated in this
investigation. Fourth, the NHANES survey only sampled
non-institutionalised and relatively healthy individuals.
The prevalence of taste and smell impairment may be
signiﬁcantly higher in persons whose health is otherwise
compromised, such as those with neurodegenerative dis-
orders.50 Finally, since only a limited number of poten-
tial risk factors were evaluated, other risk factors may
exist that have yet to be identiﬁed.
CONCLUSION
This study, based on a representative sample of the US
population, strongly suggests that a signiﬁcant number
of American citizens suffer from smell or taste problems.
Thus, 13.5% of the study population exhibited smell dys-
function, 17.3% taste dysfunction and 2.2% taste and
smell dysfunction. Since the 2016 US Census Bureau
estimates the US population ≥40 years old to be ∼152
million,51 this translates to over 43 million Americans
having some degree of chemosensory dysfunction. The
adverse consequences of these disorders are particularly
critical to older populations because approximately one-
ﬁfth of those sampled could not identify the test odours
of smoke and natural gas, in accord with other studies
on this topic.52 As shown in the NHANES study, age,
gender, ethnicity, educational attainment, family
income, light-to-moderate alcohol consumption and
history of asthma or cancer were potential risk factors
for smell dysfunction. Risk factors for taste dysfunction
were more limited, being conﬁned only to ethnicity,
heavy alcohol consumption and a history of CVD. Future
prospective investigations are needed to establish more
clearly the link between these and other risk factors and
the development of chemosensory disturbances.
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